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Epithelial–mesenchymal interactions that govern the development of the colon from the primitive gastrointestinal tract are still unclear. In this
study, we determine the temporal–spatial expression pattern of Fibroblast growth factor 10 (Fgf10), a key developmental gene, in the colon at
different developmental stages. We found that Fgf10 is expressed in the mesenchyme of the distal colon, while its main receptor Fgfr2-IIIb is
expressed throughout the entire intestinal epithelium. We demonstrate that Fgf10 inactivation leads to decreased proliferation and increased cell
apoptosis in the colonic epithelium at E10.5, therefore resulting in distal colonic atresia. Using newly described Fgf10 hypomorphic mice, we
show that high levels of FGF10 are dispensable for the differentiation of the colonic epithelium. Our work unravels for the first time the pivotal
role of FGF10 in the survival and proliferation of the colonic epithelium, biological activities which are essential for colonic crypt formation.
© 2006 Elsevier Inc. All rights reserved.Keywords: Fgf10; Fgf10 hypomorph; Colon development; Atresia; Proliferation; Survival; Differentiation; Crypt formation; Progenitor cellsIntroduction
The development of the gastrointestinal (GI) tract starts 2
days after gastrulation when the endoderm germ layer,
consisting of an unspecified group of cells, turns into a patterned
gut tube surrounded by the mesoderm (Grapin-Botton and
Melton, 2000; Roberts, 2000). The mesoderm differentiates
uniformly into smooth muscles and connective tissue along the
proximal–distal axis of the gut, while the endoderm differenti-
ates with regional specification (Kedinger et al., 1988; Traber,
1998). Morphologically and functionally, the developing gut
tube is subdivided into 3 regions: foregut, midgut and hindgut.
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doi:10.1016/j.ydbio.2006.08.001and liver. The midgut and hindgut give rise to the small intestine
and colon, respectively, with the cecum forming the boundary
between the small intestine and the colon (Mathan et al., 1976;
Wells and Melton, 1999).
Regionalization of the primitive gut tube is orchestrated by
mesenchymal–epithelium interactions (Haffen et al., 1987;
Kedinger et al., 1998; Koike and Yasugi, 1999; Roberts,
2000). The proliferation of the intestinal epithelium and me-
senchyme is tightly coordinated with the specification of the
different GI tract domains along the proximal–distal axis.
Interestingly, the control of cell proliferation and differentiation
along the proximal–distal axis of the GI tract during develop-
ment is poorly understood at this time since most of the studies
on GI tract have used adult intestine as a model system.
Identification of the growth factors controlling these processes is
crucial since the molecular mechanisms regulating organoge-
nesis are often the same as those necessary for repair following
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embryonic signaling pathways are often associated with
neoplastic diseases (Clark et al., 2001).
Fibroblast growth factor (Fgf ) genes encode a large family
of secreted molecules, which consists of 22 members in both
mouse and human. These growth factors act through tyrosine
kinase transmembrane receptors encoded by at least four
separate genes (McKeehan et al., 1998). Each Fibroblast
Growth Factor receptor (FGFR) comprises an extracellular
region composed of two or three immunoglobulin-like (Ig)
domains, a transmembrane segment and an intracellular
tyrosine kinase domain (Johnson and Williams, 1993; McKee-
han et al., 1998). Alternative splicing of the exons that encode
the C-terminal half of the third Ig domain in Fgfrs-1, -2 and -
3 results in receptor isoforms termed ‘IIIb’ or ‘IIIc’, each with
respectively distinct ligand-binding specificity and tissue
distributions (Ornitz et al., 1996; Ornitz and Itoh, 2001).
The Fgfr2 gene splice variant containing the IIIb exon (Fgfr2-
IIIb, hereafter Fgfr2b) is expressed mainly in epithelia, and is
activated by four known ligands, FGFs-1, 3, 7 and 10, which
are synthesized predominantly within the mesenchyme. In
contrast, FGFR2-IIIc (FGFR2c) is located primarily in the
mesenchyme (Peters et al., 1992; Orr-Urtreger et al., 1993;
Mason, 1994; Ornitz et al., 1996; Bellusci et al., 1997). FGF
signaling plays important roles in controlling tissue patterning,
proliferation and differentiation in multiple developing organs.
In particular, stimulation of FGFR2b has been shown to
trigger proliferation of the intestinal epithelium in the adult
(Housley et al., 1994). We have also previously described that
Fgfr2b plays also a critical role in embryonic GI tract
development (Fairbanks et al., 2006). However, the specific
roles of FGFR2b known ligands in controlling survival,
proliferation, differentiation and morphogenesis during colonic
development are still unclear.
We previously reported that Fibroblast growth factor 10
(Fgf10) is critical for the proper development of the stomach
(Spencer-Dene et al., 2006), the duodenum (Kanard et al., 2005)
and the cecum in the mouse (Burns et al., 2004). We have also
reported that the gut abnormalities observed in the Fgf10 null
embryos are not the consequence of mesenteric vasculature
occlusion (Fairbanks et al., 2005). In this study, we expand our
analysis of Fgf10 expression and the corresponding null
phenotype to more distal regions of the GI tract. Using a
mouse reporter line where LacZ is expressed under the control of
Fgf10 regulatory sequences, we describe the precise temporal–
spatial expression of Fgf10 during colon development. Using
immunohistochemistry with FGFR1 and FGFR2 antibodies, we
describe the expression of FGF10 receptors along the proximal–
distal axis of the developing colon. The colon phenotype of
Fgf10 null embryos at different developmental stages is also
analyzed. We demonstrate that FGF10 plays a critical role in the
survival and proliferation of the colonic epithelial progenitor
cells during embryonic development. Analysis of differentiation
in the Fgf10 hypomorph using immunostaining suggests that
FGF10 is not critical for the differentiation of the epithelium and
mesenchyme but plays an important role in crypt formation.
Thus our work demonstrates that FGF10 is necessary forsurvival and proliferation of the epithelium, biological activities
essential for crypt formation. In contrast, FGF10 is not required
for the differentiation of the epithelium andmesenchyme located
in the distal region of the colon.
Materials and methods
Mutant embryos
The Mlc1v-nLacZ-24 (hereafter Fgf10LacZ/+) mouse line is bred on a mixed
background and has been previously described (Kelly et al., 2001). The
transgene containing an nLacZ reporter gene is integrated upstream of the Fgf10
gene. Fgf10LacZ/− embryos (Mailleux et al., 2005) were generated by crossing
Fgf10+/− on a C57Bl/6 background (Sekine et al., 1999) with Fgf10LacZ/+ mice.
Offspring were genotyped as previously described (Mailleux et al., 2005). The
total number of mutant embryos use in this study are: Fgf10−/− (E10.5, n=5;
E11.5, n=5; E12.5, n=4; E13.5, n=6; E14.5, n=5; E15.5, n=10; E18.5, n=8;
P0, n=3), Fgf10−/+ (E10.5, n=10) and Fgf10LacZ/− (E12.5, n=8; E14.5, n=7;
E15.5, n=10; E18.5, n=8; Po, n=3).
Whole-mount in situ hybridization and LacZ staining
All samples for in situ hybridization were fixed in 4% paraformaldehyde
(PFA) in PBS at 4°C. The fixation time was adjusted for the age of gestation as
follows: E10.5, 30 min; E11.5, 1 h; E12.5, 2 h; E15.5, overnight. The samples
were washed twice in PBS for 5 min, washed in 70% ethanol over night and
stored in 100% ethanol until needed. The murine cDNA used as templates for
riboprobes was a 584 b Fgf10 cDNA (described by Bellusci et al. (1997), a 1 kb
Hnf-3β cDNA, a 642 b Shh cDNA, a 1.8 kb Ihh cDNA and a 1.5 kb full-length
Bmp4 cDNA. The whole-mount in situ hybridization protocol has been
described by Winnier et al. (1995). LacZ expression on whole-mount colon was
monitored by β-galactosidase activity as described by Kelly et al. (1995).
Proliferation analysis
Intraperitoneal injection of 0.2 ml Bromodeoxyuridine (BrdU, Amersham
Biosciences UK Limited) was given to pregnant female mice at E10.5. The mice
were sacrificed after 15 min. The colon was dissected from the embryo,
preserved in 4% PFA solution as described above and processed for paraffin
sectioning. Dissection and orientation of tissue were standardized to facilitate
identification of structures. The embedded specimens were sectioned at 5 μm.
The sections were then incubated with monoclonal anti-bromodeoxyuridine
(Clone BU-1) RPN 202 as recommended by the manufacturer (Amersham
Biosciences). Cy3 labeled anti-mouse secondary antibodies were used
(Jackson). Vectashield with DAPI was used as a mounting medium. The
sections were photographed using fluorescence microscopy.
Cell death analysis
The “In Situ Cell Death Detection, Fluorescein” kit (TUNEL technology,
from Roche Applied Science) for detection and quantification of apoptosis was
used per manufacturer protocol on 5 μm paraffin sections of E10.5 Fgf10+/+,
Fgf10+/− and Fgf10−/− colons.
Data analysis
For analysis of cell proliferation and cell death, we compared samples from
the same litter. The statistics presented correspond to an experiment including 2
wild type, 2 Fgf10−/+ and 2 Fgf10−/− embryos harvested from the same litter. The
experiments were repeated with two other litters (3 Fgf10−/− embryo and 3 wild
type embryos) and a drastic reduction in epithelial proliferation and increase in
cell death between Fgf10−/− and wild type colons was noted. The presented data
are representative of the results obtained with the other litters.
After staining for BrdU incorporation or TUNEL, the total number of
epithelial cells per section are counted (average 200 cells/section), as well as the
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cells is determined. The data are expressed as a mean of the ratio±standard
deviation.
Immunostainings
The colon was dissected from embryos at different stages of development
(E12.5 to E18.5), fixed overnight in formalin and stored in 70% alcohol. The
tissues were embedded in paraffin and 5 μm cross-sections were made. For Ki-
67 and ephrin-B immunostaining, antigen retrieval was performed by boiling the
samples for 20 min in Na-Citrate buffer (10 mM pH 6.0). Incubation of
antibodies directed against Ki-67 (1:100, Novocastra) and ephrin-B1 (1:50,
Santa Cruz Inc.) was performed in TBS with 3% bovine serum albumin and
0.5% Triton overnight at 4°C. A Cy3 conjugated goat anti-rabbit was used as
secondary antibody for both antibodies; vectashield with DAPI was used as a
mounting medium. For FGFR1 and FGFR2 immunostainings, antigen retrieval
was performed by boiling the samples for 20 min in Tris–EDTA (pH 9.0).
FGFR1 antibody (Flg, 1:200, Santa Cruz Inc.) and FGFR2 antibody (Bek,
1:200, Santa Cruz Inc.) were incubated for 1 h at room temperature. The signals
were visualized with Envision+ Dual Link Kit (Invitrogen) as recommended by
the manufacturer.
Histological stainings
5 μm cross-sections were obtained as described above. The sections were
stained with hematoxylin and eosin according to standard procedures or with
alcian blue as described in http://www.ihcworld.com/_protocols/special_stains/
alcian_blue.htm.
Morphometric analysis of the wild type and mutant colons
Wild type (n=4), Fgf10 hypomorphic (n=4) and Fgf10 null (n=4) colons at
E18.5 were photographed at the same magnification. The length (in arbitrary
units or a.u.) of each colon was measured using the software ImageJ from the
NIH. For the wild type colons, we measured the length from the cecum to the
rectum. For the mutant colons, we measured the length form the cecum to the
site of atresia. The average length for wild type, Fgf10 hypomorphic and Fgf10
null colons was calculated and compared. The data are expressed as a mean±
standard deviation. We also calculated the ratios of the average length of the
mutants colon compared to the average Length of the wild type colon. The
significance of the differences between length was evaluated by ANOVA.
P values less than 0.05 were considered statistically significant.
Results
Fgf10 is expressed in the embryonic colon
We investigated the expression pattern of Fgf10 in the colon
between embryonic day 10.5 (E10.5) and E18.5 using Fgf10-
mice (Kelly et al., 2001). Previous studies suggest that this
mouse strain is a useful reporter for Fgf10 expression in several
organs (Kelly et al., 2001; Mailleux et al., 2005; Veltmaat et al.,
2006). In order to validate the usefulness of these mice in the
developing colon, we compared the expression of β-galactosi-
dase to Fgf10 mRNA expression using whole-mount in situ
hybridization (WM-ISH) between E10.5 and E14.5. β-galacto-
sidase activity is first detected only in the distal-most region of
the colonic mesenchyme at E10.5 (Figs. 1A, A′). A similar
expression pattern is observed for Fgf10 (Fig. 1B). The β-
galactosidase expression domain extends proximally to encom-
pass the distal half of the colon at E12.5 (Fig. 1C). At E14.5 and
E18.5, the β-galactosidase expression continues to extend
proximally and is seen in the entire colon with the exceptionof the proximal-most region (Figs. 1E and G, respectively). A
similar expression pattern is observed for Fgf10 WM-ISH
(insets in Figs. 1C and E). Vibratome sections at the level of the
distal colon show that β-gal and Fgf10 are expressed throughout
the mesenchyme but not in the epithelium at E12.5 (Figs. 1C′,
D). At E14.5, β-gal and Fgf10 expressions are absent from the
mesenchyme immediately adjacent to the epithelium (Figs. 1E′,
F). At E18.5, β-galactosidase is expressed in the muscular layer
and the serosa (Figs. 1G′, Gʺ). Our results therefore indicate that
LacZ expression in Fgf10LacZ/+ mice is a reporter for Fgf10
expression in the developing colon. We also show that Fgf10
starts to be expressed in the distal part of the colon and expands
proximally at later stages.
FGFR1 and FGFR2 are expressed throughout the colon
Immunohistochemistry at different developmental stages was
carried out to determine the expression of FGFR1 and FGFR2.
These antibodies recognize both the “b” isoform, generally
expressed in epithelia, and the “c” isoform usually expressed in
mesenchyme. FGF10 binds to the “b” isoform of both receptors.
At E12.5, FGFR1 is expressed at low levels in the epithelium
(Fig. 2F). By E14.5, FGFR1 expression extends into the me-
senchyme (Fig. 2G). At E18.5, FGFR1 staining is strongly
localized to the muscular layer and is expressed at lower levels in
the remaining mesenchyme and the epithelium throughout the
entire colon (Figs. 2H–J). FGFR2 is strongly expressed in both
the epithelium and the mesenchyme at E12.5 and E14.5 (Figs.
2K and L, respectively). At E18.5, FGFR2 is expressed in the
proximal region that does not express Fgf10 (Fig. 2M), as well
as in the mid and distal regions expressing Fgf10 (Figs. 2N and
O, respectively). FGFR2 is mainly expressed in the epithelium
but also at lower levels in the muscular layers and the serosal
lining. Because the antibodies used for this study do not
discriminate between the “b” and “c” isoforms of FGFR2, we
performed a WM-ISH at E12.5 for Fgfr2b. The staining shows
uniform expression of this receptor isoform throughout the entire
GI tract epithelium (Fig. 2K, inset). The presence of FGF10 and
the receptors FGFR1 and FGFR2 in the colon suggest a function
for FGF10 in colon development. Moreover, the specific
expression of the Fgfr2b isoform in the epithelium makes the
epithelium a likely target for FGF10.
Fgf10 inactivation leads to colonic atresia
WM-ISH for Hepatocyte nuclear factor 3β (Hnf3β), a
specific marker of the epithelium in endoderm-derived organs,
was used to determine the status of the gut epithelium in wild
type and Fgf10 null colons at different developmental stages.
At E10.5, the wild type GI tract consists of a tube of uniform
diameter with a slight narrowing of the diameter at about one
third of the length from the proximal end of the hindgut (Fig.
3A). The Fgf10−/− GI tract shows a greater reduction in diameter
at that point in the hindgut than the wild type, while the midgut
appears normal (Fig. 3B). At E11.5, the cecum starts to develop,
separating the colon from the rest of the intestine. At this stage,
the colon has elongated significantly (Fig. 3C). In Fgf10−/−
Fig. 1. Fgf10 expression during colonic development. Comparison of X-gal staining of whole-mount Fgf10LacZ/+ GI tract (A, A′, C, E, G) and Fgf10 expression by
WM-ISH with Fgf10 antisense probe (B and insets in C and E). (A–B) At E10.5, Fgf10 is expressed in the distal part of the hindgut (yellow arrow). (C) At E12.5, the
expression of Fgf10 extends proximally (WM-ISH for Fgf10 in inset). (C′) Vibratome sections of the X-gal staining and (D) WM-ISH show that the entire
mesenchyme expresses Fgf10. (E) At E14.5, Fgf10 is expressed in the entire colon with the exception of the very proximal region adjacent to the cecum (WM-ISH in
inset). (E′) Corresponding sections of the X-gal staining and (F) WM-ISH show that the mesenchyme immediately adjacent to the epithelium does not express Fgf10.
(G) At E18.5, Fgf10 is still strongly expressed in most of the colon except the proximal region. (G′) Section of the mid colon stained with X-gal shows LacZ
expression in the mesenchyme, mostly in the muscular layer and the serosa. (G″) High magnification of panel G′. Dashed lines indicate the border between the
epithelium and the mesenchyme. m, mesenchyme; e, epithelium; mg, midgut; c, cecum; si, small intestine; m, mesenchyme; e, epithelium; gt, genital tubercle.
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while the formation of the cecum is arrested as previously
reported (Burns et al., 2004). The epithelium is absent in two
discrete regions, one located in the proximal region of the colon,
and one located in the distal region of the colon (Fig. 3D). At this
stage, the colonic mesenchyme is still visible in the mutantcolon. At E12.5, the wild type colon continues to enlarge and
elongate and the epithelium strongly expresses Hnf3β (Fig. 3E).
By contrast, the distal colonic epithelium of the Fgf10 null
mutants shows a weak expression ofHnf3β compared to the wild
type. There is also an interruption of the continuity of the
mesenchyme (arrow “a” in Fig. 3F). At E14.5, the colon of the
Fig. 2. FGFR1 and FGFR2 expression in the embryonic colon. Immunohistochemical analysis of E12.5, E14.5 and E18.5 wild type colonic sections stained with anti-
FGFR1 (F–J) or anti-FGFR2 (K–O) polyclonal antibodies. Control stainings (A–E), in which the primary antibody was absent, show no signal. (F–J) FGFR1 is
expressed at low levels in the epithelium at E12.5. At E14.5 and E18.5, FGFR1 staining is present in the epithelium and the mesenchyme with stronger expression in
the muscular layer throughout the colon. (K–O) FGFR2 is expressed in both mesenchyme and epithelium at all stages. At E18.5, FGFR2 staining is mainly expressed
in the epithelium, the muscular layer and the serosa of the entire colon (inset in K). WM-ISH with a specific probe for Fgfr2b on E12.5 wild type GI tract shows a
staining in the epithelium.
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type (Fig. 3G). At E18.5, the colon of the Fgf10−/− mutant is
almost completely absent. A small pouch adjacent to the cecum
is representative of the residual colon (Fig. 3J), while the wild
type colon continues to elongate (Fig. 3I). We conclude that
absence of Fgf10 signaling in the developing GI tract con-
sistently leads to an atresia of the colon from very early
developmental stages onwards.
FGF10 is required for survival and proliferation of epithelial
progenitor cells in the colon
In order to study the biological processes underlying the
appearance of colonic atresias in the Fgf10 null embryos, we
determined cell proliferation and apoptosis in wild type,Fgf10+/− and Fgf10−/− colons. Our analysis is done at E10.5,
a stage where the atresia is not yet visible in the null mutant
(Fig. 3B). Figs. 4A–C show BrdU staining of the colon in the
epithelium and mesenchyme. Fig. 4D summarizes the pro-
liferative activity of the epithelium in the different genotypes.
We found a reduction in the percentage of BrdU positive cells in
the epithelium of Fgf10 null embryos compared to wild type
colon (5.8±1.3% vs. 32±0.8%, respectively, n=2 for each
genotype). Interestingly, Fgf10+/− embryos show an intermedi-
ate number of BrdU positive cells (24.5±0.7%, n=2),
suggesting that the colonic epithelium is sensitive to FGF10
dosage for its growth. Figs. 4E–G illustrate the results for
TUNEL staining of the colon at E10.5. Fig. 4H summarizes the
index of apoptosis in the epithelium for the different genotypes.
The apoptotic index increases with decreased Fgf10 levels
Fig. 3. Absence of FGF10 results in defective colon development. Morphologic comparison of the development of the colon in WT (A, C, E, G, I) and Fgf10−/− (B, D, F, H, J) embryos at E10.5, E11.5, E12.5, E14.5 and
E18.5. (A–F) WH-ISH for Hnf-3β, a marker of the epithelium. (A) At E10.5, the midgut and hindgut of the wild type embryos elongates. (C, E) Regionalization along the proximal–distal axis of the GI tract forms the
small intestine, the cecum and the colon at E11.5 and E12.5. (B) The Fgf10−/− embryos first show a reduction of the diameter of the colon at E10.5 followed by (D) interrupted expression of Hnf3β in the colonic
epithelium at E11.5 (arrows a) and (F) complete atresia at E12.5. (G, I) Wild type colon at E14.5 and E18.5. (H, J) Fgf10−/− embryos show a normal small intestine, no cecal epithelium and an atresia of the colon
compared to the respective wild type. si, small intestine; c, cecum; a, atresia.
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Fig. 4. Decreased proliferation and increased apoptosis in Fgf10+/− and Fgf10−/− colon vs. WT. (A–C) BrdU-labeling of E10.5 Fgf10+/+ (A), Fgf10+/− (B), and
Fgf10−/− (C) colonic sections. (D) Quantification of the percentage of BrdU-positive epithelial cells showing a significant decrease of proliferating epithelial cells
in Fgf10+/− and Fgf10−/− compared to wild type (**P<0.001). (E–G) TUNEL labeling of E10.5 Fgf10+/+ (E), Fgf10−/+ (F) and Fgf10−/− (G) colonic sections.
(H) Quantification of the percentage of TUNEL positive epithelial cells showing a significant increase of apoptosis in Fgf10+/− and Fgf10−/− colon compared to
wild type counterpart (*P<0.05).
379F.G. Sala et al. / Developmental Biology 299 (2006) 373–385(Fgf10+/+, 3.8±1.7%; Fgf10+/−, 21±15.5%; Fgf10−/−, 54.5±
6.4%; n=2 for each genotype). Overall, our data indicate that
FGF10 is required, in a dose-dependent manner, for the survival
and proliferation of the intestinal epithelial progenitor cells of
the embryonic colon. We propose that the low proliferation and
high cell death rates in absence of FGF10 lead to a loss of distal
colonic epithelium and consequently to the colonic atresia
observed in the Fgf10 null embryos.
Fgf10 hypomorphic embryos display a less severe phenotype
compared to Fgf10 null embryos
The absence of distal colon at the late developmental stages
in the Fgf10 null embryos prevents the study of the role of
FGF10 in the differentiation of the epithelium. To circumvent
this limitation, we generated Fgf10 hypomorphic mutants
(Fgf10LacZ/−) by crossing Fgf10+/− mice with Fgf10LacZ/+
mice as previously described (Mailleux et al., 2005; Veltmaat
et al., 2006). Figs. 5A and B show, respectively, the colons of an
Fgf10LacZ/+ embryo and an Fgf10LacZ/− embryo at E18.5. These
are stained with X-gal to reveal the Fgf10 expression domain.
In order to quantify the extent of colon left in mutant and wild
type gut at E18.5, we measured the length of the colon in mutant
embryos from the cecum to the site of atresia and compared this
length to the length of the colon in wild type embryos measured
from the cecum to the rectum (n=4 for each genotype). The
average length for wild type, Fgf10 hypomorphic and Fgf10
null colon is 1959 a.u±341, 1100 a.u.±221 and 392 a.u.±55,
respectively. The difference between Fgf10 null and wild type,
Fgf10 hypomorph and wild type, and between Fgf10 null and
Fgf10 hypomorph is statistically significant (P<0.001). In all
cases examined, there is more residual colonic tissue in
Fgf10LacZ/− colons (56.1%, of the length of the wild type
colon) in comparison to the residual colonic tissue observed inthe Fgf10−/− colons at the same stage (20% of the length of the
wild type colon) (Fig. 5C).
In order to determine the consequences of reduced Fgf10
levels on epithelial morphogenesis, we carried out histological
analysis of cross-sections in the proximal and mid regions of
Fgf10LacZ/+, Fgf10 hypomorphic and Fgf10 null colons at
different developmental stages. At E12.5, the epithelium is
pseudostratified all along the proximal–distal axis of the colon
(Kaufman, 1992). At this stage, the Fgf10 hypomorph and the
Fgf10 null colons display epithelial hypocellularity compared
to the wild type (Figs. 5D–H). At E14.5, the epithelium of the
wild type colon changes to columnar epithelium and folds to
form the future crypts (Calvert and Pothier, 1990; Mathan et
al., 1976; Schmidt et al., 1988) (Figs. 5I, L). In the Fgf10LacZ/−
mice, the epithelium of the proximal (Fig. 5J) and mid colon
(Fig. 5M) fails to fold and remains in a pseudostratified state.
In the Fgf10−/− embryo, the epithelium of the proximal colon
shows hypocellularity and stays in a pseudostratified state (Fig.
5K). At E18.5, the wild type colon exhibits well-formed crypts
in the proximal region (Fig. 5N) as well as the mid region (Fig.
5Q). At this stage, the Fgf10LacZ/− colon shows defined but
shortened crypts in the proximal region (Fig. 5O) while the
mid region exhibits an enlarged lumen with rudimentary crypts
and meconium accumulating in the lumen (Fig. 5R). The
proximal region of the Fgf10−/− colon also displays shortened
crypts (Fig. 5P). We conclude that FGF10 is involved in the
proper formation of the crypts in the mid and distal regions of
the colon.
Differentiation of colonic epithelium can occur with reduced
levels of Fgf10 expression
To investigate the role of FGF10 in the differentiation of the
epithelium, we stained cross-sections of Fgf10 hypomorphic
Fig. 5. Less severe phenotype of the Fgf10 hypomorphic colon compared to the Fgf10−/− colon. (A–C) Morphologic comparison of Fgf10LacZ/+ (A), Fgf10LacZ/− (B) and Fgf10−/− (C) colons at E18.5. Fgf10LacZ/+ and
Fgf10Lac/− colons have been stained with X-gal to visualize the Fgf10 expressing region. Colons of Fgf10LacZ/− embryos show an atresia in the Fgf10 expressing domain (B), located more distally than the atresia
observed in the Fgf10−/− colon. (D–R) Hematoxylin and eosin staining in the proximal region that does not express Fgf10 and in the mid region expressing Fgf10 of Fgf10LacZ/+, Fgf10LacZ/− and Fgf10−/− colonic
sections at E12.5, E14.5 and E18.5. In Fgf10LacZ/+ colons, the crypts begin to form at E14.5 (I, L) with a multi-layered epithelium. At later stages, the epithelium folds to form well-defined crypts (N, Q). (M) Fgf10
hypomorphic mid colon shows absence of multi-layering of the epithelium at E14.5 and a progressive enlargement of the lumen. (R) The Fgf10lacZ/− mid colon fails to develop crypts at E18.5. (O, P) Note that defined
crypts with reduced depth are forming in the proximal part of the colon that does not express Fgf10 in both Fgf10LacZ/− and Fgf10−/− embryos. Scale bar: D–H: 50 μm, I–M: 60 μm, N–R: 125 μm.
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381F.G. Sala et al. / Developmental Biology 299 (2006) 373–385colon and corresponding regions of wild type colon on the first
day of life (P0) with markers for undifferentiated and
differentiated intestinal epithelial cells. Figs. 6A–B′ show Ki-
67 staining, a marker of the proliferating cells (Batlle et al.,
2002). In the wild type, cells at the base of the crypts are
positive for Ki-67 (Figs. 6A, A′). In the Fgf10LacZ/− colon,
clusters of cells labeled for Ki-67 alternate with clusters of cells
negative for this marker (Figs. 6B, B′). Figs. 7C–D′ show
ephrin-B staining, a marker of terminally differentiated
intestinal epithelial cells (Batlle et al., 2002). In the wild type
colon, the apices of the crypts are stained, while the bases of the
crypts are devoid of signal (Figs. 6C, C′). In the Fgf10LacZ/−
colon, ephrin-B is expressed in discrete regions separated by
clusters of cells without staining (Figs. 6D, D′). Figs. 6E–F′
show alcian blue staining of goblet cells in wild type and Fgf10
hypomorphic colon. As in the wild type (Figs. 6E, E′), goblet
cells differentiate properly in theFgf10LacZ/− colon (Figs. 6F, F′).
We therefore conclude that reduced levels of Fgf10 expression
do not affect the differentiation of the epithelium.
FGF10 is not required for proper development of the
mesenchyme
Shh and Ihh are genes known to directly control the diff-
erentiation of the mesenchyme and affect crypt formationFig. 6. Normal levels of Fgf10 are not critical for differentiation of the colonic
proliferating cells. (C–D′) IF staining for ephrin-B, a marker of differentiated cells. (
(A, A′, C, C′, E, E′) and Fgf10LacZ/− (B, B′, D, D′, F, F′) mid colonic sections. Panels
B, C, D E and F, respectively. In the wild type, the proliferating cells are located at the
and goblet cells (E, E′) are located at the upper region of the crypts. The Fgf10LacZ/− c
(D, D′) and goblet cells (F, F′). Arrows indicate the base of the crypts in the wild ty(Madison et al., 2005; Ramalho-Santos et al., 2000). Bmp4 also
regulates crypt formation, but its mechanism of action on the
epithelium or mesenchyme is still unclear (Haramis et al.,
2004). We performed a WM-ISH to study the role of FGF10 in
the regulation of these genes. Shh, Ihh and Bmp4 are expressed
at various levels throughout the developing gut either in the
epithelium (Shh and Ihh, Figs. 7A, C respectively) or in the
mesenchyme (Bmp4, Fig. 7E). No difference was found in the
level or the pattern of expression of these genes at E15.5
between the wild type and the Fgf10 hypomorphic mutants
(Figs. 7A–F). To assess the differentiation of the mesenchyme
in more detail, we used immunofluorescence at E18.5 to
analyze alpha smooth muscle actin (α-SMA), a marker for the
intestinal subepithelial myofibroblasts (ISEMFs), and desmin, a
marker for smooth muscle cells. Expression of α-SMA (Figs.
7G, H) and desmin (Figs. 7I, J) appears unchanged between the
Fgf10 hypomorphic and the wild type colons. We therefore
conclude that reduced levels of Fgf10 expression do not affect
the differentiation of the mesenchyme.
Discussion
The restricted expression pattern of Fgf10 along the
proximal–distal axis of the developing GI tract suggests that
regionalization of the GI tract into distinct anatomical andepithelium. (A–B′) Immunofluorescence (IF) staining for Ki67, a marker of
E–F′) Alcian blue staining of terminally differentiated goblet cells. P0 wild type
A′, B′, C′, D′, E′ and F′ are higher magnification views of the boxes in panels A,
base of the crypts (A, A′), and the differentiated cells expressing ephrin-B (C, C′)
olons show groups of proliferating cells (B, B′) and groups of differentiated cells
pe and the presumptive crypt regions in the hypomorphic mutant.
Fig. 7. Mesenchymal differentiation of the Fgf10LacZ/− colon. Whole-mount in situ hybridization on E15.5 wild type or Fgf10LacZ/− colons for Shh (A, B); Ihh (C, D)
and Bmp4 (E, F). In the wild type, Shh and Ihh are expressed in the epithelium, and Bmp4 is expressed in the mesenchyme. In the Fgf10LacZ/− colon, the expression of
these genes is not affected by low levels of Fgf10. IF staining of E18.5 wild type and Fgf10LacZ/− colonic sections for α-SMA (G, H) and desmin (I, J). Low levels of
Fgf10 do not affect the expression of α-SMA and desmin. c, cecum.
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Fgf10, expressed in most of the developing colon, plays a
pivotal role in both survival and proliferation of intestinal
epithelial progenitor cells, activities essential for crypt forma-
tion. In addition, using Fgf10 hypomorphic mice, we
demonstrate for the first time that reduced levels of Fgf10 are
sufficient for the differentiation of the colonic epithelium and
mesenchyme.
FGF10 dosage is important for proper colonic development
Total inactivation of Fgf10 leads to a complete loss of the
distal part of the colon from an early stage of embryonic
development. Many forms of intestinal atresia are thought to be
the consequence of a mesenteric vasculature occlusion.
However, Fairbanks et al. (2005) demonstrated that the absence
of Fgf10 does not affect the proper development of the
mesenteric vasculature. Our work demonstrates that the
observed colonic atresia in Fgf10 null embryos is indeed the
consequence of significant reduction in proliferation and
increased apoptosis in the Fgf10 mutant colonic epithelium
compared to the heterozygous and wild type colons. Similar to
the development of the bladder, urethral tube and prostate
(Bagai et al., 2002; Donjacour et al., 2003; Petiot et al., 2005),
FGF10/FGFR2b signaling is critical for the maintenance and
the proliferation of the epithelial progenitor cells of the colon.
Our results also indicate that the colon of Fgf10+/− mice,
although phenotypically normal at birth (data not shown),
displays lower proliferation and higher cell death in the
epithelial layer at E10.5 than the corresponding wild type. At
even lower Fgf10 levels, as demonstrated in the Fgf10
hypomorphic embryos, normal crypt architecture fails to
develop. Evidence is accumulating that FGF10 dosage iscritical for proper development of many organs, including the
lung (Mailleux et al., 2005), the mammary glands (Veltmaat et
al., 2006) and the limbs (Bellusci, unpublished results).
Moreover, Entesarian and colleagues (2005) have recently
shown the importance of FGF10 dosage for salivary and
lacrimal gland development in humans. Individuals with
autosomal dominant aplasia of lacrimal and salivary gland
(ALSG) were found to be heterozygous for FGF10. Comple-
mentary studies in adult Fgf10+/− mice revealed that Fgf10
heterozygotes have absent parotid and smaller submandibular
glands (Jaskoll et al., 2005). Our results demonstrate that the
morphogenesis of the colon is indeed Fgf10 dose-dependent.
Distinct signaling pathways control the proliferation of the
proximal and distal colon
Comparison of the histology of the proximal region of the
Fgf10 hypomorphic and Fgf10 null colons demonstrates that
crypts are forming even in absence of Fgf10. This result
suggests that other signaling pathways, independent of the
FGF10 signaling pathway, are critical for the control of
epithelial progenitor cell survival and proliferation in the
proximal region of the colon. An identical phenotype was
observed in the Fgfr2b−/− embryos (Fairbanks et al., 2006)
suggesting that neither FGF10 nor FGFR2b is critical for
development of the proximal region of the colon.
The signaling pathways regulating proximal colonic pro-
liferation remain to be identified. A potential pathway for
controlling the survival and proliferation of the epithelium in the
proximal region of the colon is the canonical Wnt signaling
pathway. Components of the Wnt signaling pathway have been
shown to be expressed in the embryonic GI tract (Theodosiou
and Tabin, 2003). In addition, the Wnt signaling pathway
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(Pinto et al., 2003; van de Wetering et al., 2002). More work
will have to be done to test the role of Wnt signaling during
colon embryogenesis.
Reduced levels of Fgf10 are sufficient for the differentiation of
intestinal epithelial cells
The FGF10 pathway has been shown to control epithelial
differentiation in many organs, including the lung and the
stomach. In the lung, FGF10 loaded heparin sepharose beads
grafted at the level of the trachea can trigger formation of an
ectopic bud expressing surfactant Protein C, a marker of type II
pneumocytes (Hyatt et al., 2004). This result demonstrates that
FGF10 is sufficient to reprogram the tracheal epithelium to
become respiratory epithelium. We have also reported that
Fgf10−/− and Fgfr2b−/− stomachs are smaller than the wild type
stomachs, and that during mid to late fetal stages (E15.5–18.5)
epithelial differentiation of mucous and chief cell lineages is
rudimentary, with no expression of several early cytodiffer-
entiation markers, including GATA4, GATA6, H+/K+-ATPase
and abnormal expression of members of the Hedgehog family
of signaling molecules (Spencer-Dene et al., 2006). Moreover,
activation of FGFR2b signaling by FGF7 has previously been
shown to induce epithelial differentiation into goblet cells in
adult rat intestine (Housley et al., 1994).
By contrast, our results indicate that even with reduced
levels of Fgf10 the epithelium differentiates normally. It is
interesting to note that, in the Fgf10LacZ/− colon, there is
clustering of cells expressing ephrin-B alternating with clusters
of ephrin-B negative cells, suggesting that even in the absence
of normal crypt architecture, differentiated cells and undiffer-
entiated cells are still regionalized. Our results indicate that
FGF10 is not directly involved in controlling epithelial
differentiation in the colon. A similar conclusion has been
proposed concerning the role of Fgf10 in the developing
prostate as prostatic rudiments from Fgf10−/− embryos
transplanted into intact male hosts grew very little, but showed
some signs of prostatic differentiation (Donjacour et al., 2003).
These data suggest that other pathways, such as the canonical
Wnt pathway, which controls epithelial differentiation in the
adult intestine (van de Wetering et al., 2002), may control
differentiation during colonic development, while FGF10
controls epithelial survival and proliferation of the mid and
distal colonic epithelium.
FGF10 is not required for proper development of the
mesenchyme
Shh, Ihh and Bmp4 have been reported to play important
roles during gut development. For example, epithelial hedge-
hog signaling is involved in the patterning of the intestinal
crypt–villus axis by controlling the differentiation of the
intestinal subepithelial myofibroblasts that express α-SMA and
the smooth muscle cells expressing desmin (Madison et al.,
2005; Adegboyega et al., 2002; Ramalho-Santos et al., 2000;
Powell et al., 1999). Inactivation of Ihh leads to a dilated colonwith absence of crypts and an abnormally thin mesenchymal
layer (Ramalho-Santos et al., 2000), similar to the histological
findings in Fgf10LacZ/− mice. Bmp4 expressed in the
mesenchyme during intestinal development (Roberts et al.,
1995, 1998; Sukegawa et al., 2000) also represses de novo
crypt formation during adulthood (Haramis et al., 2004).
These genes or the proteins encoded by these genes have been
described to be downstream or upstream of FGF10 during the
development of many organ systems including the lung
(Warburton et al., 2001). We initially hypothesized that the
expression of these genes could therefore be altered as the
result of reduced Fgf10 expression. Our data indicate that the
expression patterns of Shh, Ihh and Bmp4 are unchanged
between wild type and Fgf10 hypomorphic colons. In
addition, we observe unchanged expression of α-SMA and
desmin in the mesenchyme in the Fgf10 hypomorphic colons
suggesting that the mesenchyme differentiates normally in
spite of reduced levels of Fgf10 expression. Interestingly, the
expression of Shh is also unchanged in Fgfr2b−/− developing
urethra (Petiot et al., 2005), and the mesenchyme appears to
differentiate normally in the mutant tissue. We therefore
conclude that these developmental genes are not controlled by
FGF10. Since the epithelium and the mesenchyme differ-
entiate properly in the Fgf10LacZ/− mice, we propose that
defective survival and proliferation in the colonic epithelium
is the underlying cause preventing normal crypt architecture
formation.
In conclusion, our work demonstrates for the first time the
crucial role played by FGF10 in colonic development. FGF10
controls survival and proliferation of the colonic epithelial
progenitor cells. These two biological activities are essential for
the proper formation of the crypts in the colon.
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